Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment

Wong Doo N, White VM, Martin K, Bassett JK, Prince HM, Harrison SJ, Jefford M, Winship I, Millar JL, Milne RL, Seymour JF, Giles GG

(2019), Cancers, 11(7), 928

DOI: 10.3390/cancers11070928

Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape

Philip J, Collins A, Ritchie D, Le B, Millar J, McLachlan SA, Krishnasamy M, Hudson P, Sundararajan V

(2019), LEUKEMIA LYMPHOMA, 60(8), 1908-16

DOI: 10.1080/10428194.2018.1564047

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators

(2019), Lancet Oncol, 20(4), 494-503

DOI: 10.1016/S1470-2045(18)30896-9

Fractionated Stereotactic Radiotherapy for Cavernous Venous Malformations of the Orbital Apex

Ratnayake GS, McNab AA, Dally MJ, Zajarski C, Senthi S, Ruben JD

(2019), OPHTHAL PLAST RECONS, 35(4), 322-5

DOI: 10.1097/IOP.0000000000001239

Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry Victoria

Ong WL, Foroudi F, Evans S, Millar J

(2019), J MED IMAG RADIAT ON, 61(1), 124-30

DOI: 10.1111/1754-9485.12818

The trajectory of patients who die from metastatic prostate cancer: a population-based study

Collins A, Sundararajan V, Millar J, Burchell J, Le B, Krishnasamy M, McLachlan SA, Hudson P, Mileshkin L, Philip J

(2019), BJU Int, 123 Suppl 5, 19-26

DOI: 10.1111/bju.14593

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

Tie J, Cohen JD, Wang Y, Li L, Christie M, Simons K, Elsaleh H, Kosmider S, Wong R, Yip D, Lee M, Tran B, Rangiah D, Burge M, Goldstein D, Singh M, Skinner I, Faragher I, Croxford M, Bampton C, Haydon A, Jones IT, S Karapetis C, Price T, Schaefer MJ, Ptak J, Dobbyn L, Silliman N, Kinde I, Tomasetti C, Papadopoulos N, Kinzler K, Volgestein B, Gibbs P

(2019), Gut, 68(4), 663-71

DOI: 10.1136/gutjnl-2017-315852

Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy

Beckman K, O'Callaghan M, Vincent A, Roder D, Millar J, Evans S, McNeil J, Moretti K

(2018), ANZ J Surg, 88(3), e183-188

DOI: 10.1111/ans.13954

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method

Tsiamis E, Millar J, Baxi S, Borg M, De Ieso P, Elsaleh H, Foroudi F, Higgs B, Holt T, Martin J, Moretti K, Pryor D, Skala M, Evans S

(2018), Radiother Oncol, 128(2), 308-14

DOI: 10.1016/j.radonc.2018.04.017

An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging

Smith RL, Hanlon M, Panettieri V, Millar JL, Matheson B, Haworth A, Franich RD

(2018), Brachytherapy, 17(1), 111-121

DOI: 10.1016/j.brachy.2017.08.004

Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management

Sampurno F, Zheng J, Di Stefano L, Millar JL, Foster C, Fuedea F, Higano C, Hulan H, Mark S, Moore C, Richardson A, Sullivan F, Wenger NS, Wittmann D, Evans S

(2018), J Urol, 200(2), 319-326

DOI: 10.1016/j.juro.2018.02.071

Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study

Papa NP, MacInnis RJ, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Severi G, Hopper JL, Giles GG

(2018), Cancer Causes Control, 29(1), 93-102

DOI: 10.1007/s10552-017-0981-0

Brachytherapy-based radiotherapy with androgen deprivation for management of high-risk prostate cancer - time to reverse the declining trend?

Ong WL, Yaxley JW, Millar JL

(2018), BJU Int, 122 Suppl 5, 43591

DOI: 10.1111/bju.14487

Optimal Treatment for High-Risk Prostate Cancer

Ong WL, Koh TL, Millar J

(2018), JAMA, 320(4), 404-405

DOI: 10.1001/jama.2018.6709

Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy

Ong WL, Evans SM, Millar JL

(2018), J Med Imaging Radiat Oncol, 62(2), 256-261

DOI: 10.1111/1754-9485.12699

In Regard to Yang et al

Ong WL, Evans S, Millar J

(2018), Int J Radiat Oncol Biol Phys, 100(5), 1294-1295

DOI: 10.1016/j.ijrobp.2018.01.019

Development of Indicators to Assess Quality of Care for Prostate Cancer

Nag N, Millar J, Davis ID, Costello S, Duthie JB, Mark S, Delprado W, Smith D, Pryor D, Galvin D, Sullivan F, Murphy °C, Roder D, Elsaleh H, Currow D, White C, Skala M, Moretti KL, Walker T, De Ieso P, Brooks A, Heathcote P, Frydenberg M, Thavaseelan J, Evans SM

(2018), Eur Urol Focus, 4(1), 57-63

DOI: 10.1016/j.euf.2016.01.016

Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03

MacManus M, Fisher R, Roos D, O'Brien P, Macann A, Davis S, Tsang R, Christie D, McClure B, Joseph D, Jayamohan J, Seymour JF

(2018), J Clin Oncol, 36(29), 2918-2925

DOI: 10.1200/JCO.2018.77.9892

Understanding the Relationship Between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy

Liu J, Dwyer T, Marriott K, Millar J, Haworth A

(2018), IEEE Trans Vis Comput Graph, 24(1), 319-329

DOI: 10.1109/TVCG.2017.2744418

Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy

Her EJ, Reynolds HM, Mears C, Williams S, Moorehouse C, Millar JL, Ebert MA, Haworth A

(2018), Phys Med Biol, 63(13), 135011

DOI: 10.1088/1361-6560/aac814

4 5 6 7 8